Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

Emergent BioSolutions, Inc. (EBS)

-NYSE
22.00 Down 0.63(2.78%) Jul 31, 4:03PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 53,884   98,107   89,102   82,436  
Cost of Revenue18,997  19,421  20,063  16,945  
Gross Profit 34,887   78,686   69,039   65,491  
Operating Expenses
Research Development30,256  29,994  28,937  30,278  
Selling General and Administrative30,089  25,399  21,955  20,501  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (25,458) 23,293   18,147   14,712  
Income from Continuing Operations
Total Other Income/Expenses Net552  351  146  28  
Earnings Before Interest And Taxes(24,906)23,644  18,293  14,740  
Interest Expense3,535  (14) -  3  
Income Before Tax(28,441)23,658  18,293  14,737  
Income Tax Expense(8,205)8,441  4,802  4,381  
Minority Interest -  5   -  128  
Net Income From Continuing Ops(20,236)15,222  13,491  10,484  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (20,236) 15,222   13,491   10,484  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (20,236) 15,222   13,491   10,484  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.